VYGR - Voyager Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.40
DETAILS
HIGH:
$18.00
LOW:
$8.00
MEDIAN:
$18.00
CONSENSUS:
$14.40
UPSIDE:
278.95%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-08 | Quinlan Amy | officer: Principal Accounting Officer | ? | -- | -- | -- |
| 2026-05-08 | Quinlan Amy | officer: Principal Accounting Officer | ? | 50,000 | $5.28 | $264K |
| 2026-05-08 | Quinlan Amy | officer: Principal Accounting Officer | ? | 28,500 | $3.68 | $105K |
| 2026-04-02 | Sandrock Alfred | director, officer: President and CEO | SELL | 11,511 | $3.87 | $45K |
| 2026-04-01 | Shiferman Gregory L. | officer: SVP and General Counsel | A-Award | 50,000 | -- | -- |
| 2026-02-24 | Sandrock Alfred | director, officer: President and CEO | SELL | 14,197 | $3.79 | $54K |
| 2026-02-24 | Jorgensen Nathan D. | officer: Chief Financial Officer | SELL | 4,668 | $3.77 | $18K |
| 2026-02-24 | Carter Todd Alfred | officer: Chief Scientific Officer | SELL | 4,174 | $3.76 | $16K |
| 2026-02-24 | Swartz Robin | officer: COO & CBO | SELL | 6,458 | $3.77 | $24K |
| 2026-02-18 | Swartz Robin | officer: COO & CBO | SELL | 3,882 | $3.44 | $13K |
| 2026-02-18 | Sandrock Alfred | director, officer: President and CEO | SELL | 11,732 | $3.41 | $40K |
| 2026-02-18 | Carter Todd Alfred | officer: Chief Scientific Officer | SELL | 3,301 | $3.44 | $11K |
| 2026-02-10 | Sandrock Alfred | director, officer: President and CEO | SELL | 12,192 | $3.78 | $46K |
| 2026-02-10 | Swartz Robin | officer: COO & CBO | SELL | 4,569 | $3.85 | $18K |
| 2026-02-10 | Carter Todd Alfred | officer: Chief Scientific Officer | SELL | 3,525 | $3.85 | $14K |
| 2026-02-06 | Ferguson Toby | officer: Chief Medical Officer | A-Award | 210,000 | $3.68 | $773K |
| 2026-02-06 | Ferguson Toby | officer: Chief Medical Officer | A-Award | 45,000 | -- | -- |
| 2026-02-06 | Carter Todd Alfred | officer: Chief Scientific Officer | A-Award | 33,000 | -- | -- |
| 2026-02-06 | Carter Todd Alfred | officer: Chief Scientific Officer | A-Award | 154,000 | $3.68 | $567K |
| 2026-02-06 | Swartz Robin | officer: COO & CBO | A-Award | 45,000 | -- | -- |
| 2026-02-06 | Swartz Robin | officer: COO & CBO | A-Award | 210,000 | $3.68 | $773K |
| 2026-02-06 | Sandrock Alfred | director, officer: President and CEO | A-Award | 86,250 | -- | -- |
| 2026-02-06 | Sandrock Alfred | director, officer: President and CEO | A-Award | 402,500 | $3.68 | $1.5M |
| 2026-02-06 | Jorgensen Nathan D. | officer: Chief Financial Officer | A-Award | 32,250 | -- | -- |
| 2026-02-06 | Jorgensen Nathan D. | officer: Chief Financial Officer | A-Award | 150,500 | $3.68 | $554K |